Boxed Warnings To Be Considered For Drugs With Risk Unique To Class
Executive Summary
A boxed warning may be warranted if a product has a unique risk profile relative to other members of its class that merits second-line use, an FDA draft guidance on safety information in labeling states
You may also be interested in...
FDA Unhappy With New Label Format Submissions; Requests Clarity, Brevity
Submissions to FDA in the new labeling format have thus far failed to meet agency expectations with regard to content requirements
FDA Unhappy With New Label Format Submissions; Requests Clarity, Brevity
Submissions to FDA in the new labeling format have thus far failed to meet agency expectations with regard to content requirements
FDA Makes Preemption Case Once And For All In Final Labeling Rule
The product liability preemption language in FDA's physician labeling rule applies to all drugs regardless of whether they are regulated by the final rule